Changchun BCHT Biotechnology Co.
SHH: 688276.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Chunlai Jiang
- Employees
- 1,241
- Headquarters
- Changchun, China
- IPO year
- 2021
- Market cap
- CN¥4.5B
- Website
- https://www.bchtpharm.com
Loading 688276…
Loading profile data…Frequently asked questions about 688276
What does Changchun BCHT Biotechnology Co. (688276.SS) do?
Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. Its products include live herpes zoster vaccine; live varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and Rabies vaccine (vero cell) for humans. The...
Where does 688276.SS trade?
Changchun BCHT Biotechnology Co. (688276.SS) trades on the Shanghai Stock Exchange.
What sector is 688276.SS in?
Changchun BCHT Biotechnology Co. (688276.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Changchun BCHT Biotechnology Co.?
Chunlai Jiang is the chief executive officer of Changchun BCHT Biotechnology Co. (688276.SS).
Where is Changchun BCHT Biotechnology Co. headquartered?
Changchun BCHT Biotechnology Co. is headquartered in China.
Does 688276.SS pay a dividend?
Yes — Changchun BCHT Biotechnology Co. (688276.SS) paid a trailing twelve-month dividend of CNY 0.17 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688276.SS go public?
Changchun BCHT Biotechnology Co. (688276.SS) completed its initial public offering in 2021.